Internal Medicine, Hematology · Columbus, OH
NPI
1710159744
Since 2008
Specialty
Internal Medicine, Hematology
Code 207RH0000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
460 W 10th Ave
Columbus, OH, 43210
Phone (614) 293-8619
Groups this clinician bills Medicare through
Medicare paid, 2024
$16K
240 services
Medicare patients, 2024
58
Average age 67
Drug cost, 2024
$4.6M
312 prescriptions
Company payments, 2025
$8,397
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sumithira Vasu was code 99232 (hospital e&m - subsequent), 134 times for 29 patients. In total Sumithira Vasu billed 240 services in 12 codes, and Medicare paid $16K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-02-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 134 | 29 | $59.71 | $8,001 |
| 99214 Office E&M - Established | Facility | 75 | 28 | $66.04 | $4,953 |
By year: 2022 $22K for 282 services; 2023 $22K for 313 services; 2024 $16K for 240 services.
Medicare prescription drug claims, 2024
In 2024, the drug Sumithira Vasu prescribed most often to Medicare patients was Jakafi (Ruxolitinib Phosphate), with 127 prescriptions and refills. In total Sumithira Vasu wrote 312 Medicare prescriptions that cost $4.6M.
Brand drugs: 255 claims; generic drugs: 57 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sumithira Vasu $8,397 ($8,397 in general payments such as food, travel and fees) from 2 companies. The largest payer was Novartis Pharmaceuticals Corporation with $6,427.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 3 | $6,427 |
| National Marrow Donor Program | 5 | $1,970 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.